DR4 subtypes and their molecular properties in a population-based study of Swedish childhood diabetes

Tissue Antigens

Volumn 47, Issue 4, 1996, Pages 275-283

  Sanjeevi, C B ^a,e   Hook P ^a   Landin Olsson, M ^b   Kockum, I ^a   Dahlquist, G ^c   Lybrand, T P ^d   Lernmark, A ^a,e  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c UMEÅ UNIVERSITY   (Sweden)

^d University of Washington   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Genetic susceptibility; HLA DQ; HLA DR; IDDM

Indexed keywords

HLA DQ ANTIGEN; HLA DR4 ANTIGEN;

ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; GENE LINKAGE DISEQUILIBRIUM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HLA SYSTEM; HUMAN; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; NEWBORN; OLIGONUCLEOTIDE PROBE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SWEDEN;

EID: 0029968375     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.1996.tb02554.x     Document Type: Article

References (48)

1. Erlich HA, Bugawan TL, Scharf S, Nepom GT, Tait B, Griffth RL. HLA-DQβ sequence polymorphism and genetic susceptibility to IDDM. Diabetes 1990: 39: 96-103.
2. Sanjeevi C, Lybrand T, DeWeese C et al. Polymorphic aminoacid variations in HLA-DQ are associated with systematic physical property changes and occurrence of insulin-dependent diabetes mellitus. Diabetes 1995: 44: 125-131.
3. Bodmer JG, Marsh SGE, Albert ED et al. Nomenclature for factors of the HLA system. 1994. Tissue Antigens 1994: 44: 1-18.
4. Gao X, Fernandez-Vina M, Shumway W, Stastny P. DNA typing for class II HLA antigens with allele-specific or group-specific amplification. I. Typing for subsets of HLA-DR4. Hum Immunol 1990: 27: 40-50.
5. Hamaguchi K, Kimura A, Dong RP et al. Specific combinations of HLA-DRB and -DQB alleles confers susceptibility while the DQB gene determines resistance to insulin-dependemt diabetes mellitus in Japanese. In: Tsuji K, Aizawa M, Sasazuki T, ed. HLA 1991, Vol. 2. Oxford: Oxford University Press, 1991: 488-492.
6. Kockum I, Wassmuth R, Holmberg E, Michelsen B, Lernmark Å. HLA-DQ primarily confers protection and HLA-DR susceptibility in Type 1 (insulin-dependent) diabetes studied in population-based affected families and controls. Am J Hum Genet 1993: 53: 150-167.
7. Rønningen KS, Spurkland A, Tait BD et al. HLA class II associations in insulin-dependent diabetes mellitus among Blacks, Caucasoids, and Japanese. In: Tsuji K, Aizawa M, Sasazuki T, ed. HLA 1991 - Proceedings of the Eleventh International Histocompatibility Workshop and Conference. Vol. 1. Oxford: Oxford University Press. 1991: 713-722.
8. Mijovic CH, Jenkins D, Penny MA. Susceptibility to Type I (insulin-dependent) diabetes mellitus is determined by MHC class II molecules. What about DR4? Diabetologia 1993: 36: 1210-1211.
9. Marsh SGE, Bodmer JG. HLA class II nucleotide sequences, 1992. Immunogenet 1993: 37: 79-94.
10. Brown JH, Jardetzky TS, Gorga JC et al. Three-dimentional structure of the human class II histocompatibility antigen HLA-DR1. Nature 1993: 364: 33-39.
11. Stern LJ, Brown JH, Jardetsky TS et al. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 1994: 368: 215-221.
12. Landin-Olsson M, Palmer JP, Lernmark Å et al. Predictive value of islet cell and insulin autoantibodies for Type I (insulin-dependent) diabetes mellitus in a popoulation-based study of newly diagnosed diabetic and matched control children. Diabetologia 1992: 35: 1068-1073.
13. Sanjeevi CB, Lybrand TP, Landin-Olsson M et al. Analysis of antibody markers, DRB1, DRB5, DQA1 and DQB1 genes and modeling of DR2 molecules in DR2 positive patients with insulin-dependent diabetes mellitus. Tissue Antigens 1994: 44: 110-119.
14. Bidwell JL, Bidwell EA, Savage DA, Middleton D, Klouda PT, Bradley BJ. A DNA RFLP typing system which positively identities serologically well-defined and ill-defined HLA-DR and DQ alleles, including DRw10. Transplantation 1988: 45: 640-646.
15. Bidwell J. DNA-RFLP analysis and genotyping of HLA-DR and DQ antigens. Immunol Today 1988: 9: 18-22.
16. Bidwell JL, Bignon JD. DNA-RFLP methods and interpretation scheme tor DR and DQ typing. Eur J Immunogenet 1991: 18: 5-22.
17. Michelsen B, Lernmark Å. Molecular cloning of a polymorphic DNA endonuclease fragment associates insulin-dependent diabetes mellitus with HLA-DQ. J Clin Invest 1987: 79: 1144-1152.
18. Lanchbury JSS, Hall MA, Welsh KI, Panayi GS. Sequence analysis of HLA-DR4B1 subtypes: additional first domain variability is detected by oligonucleotide hybridization and nucleotide sequencing. Hum Immunol 1990: 27: 136-144.
19. Petersdorf EW, Smith AG, Mickelson EM, Martin PJ, Hansen JA. Ten HLA-DR4 alleles defined by sequence polymorphisms within the DRB1 first domain. Immunogenetics 1991: 33: 267-275.
20. Erlich HA, Bugawan BL. HLA class II gene polymorphism: DNA typing, evolution, and relationship to disease susceptibility. In: Erlich HA, ed. PCR technology - principles and applications for DNA amplification. New York: Stockton Press, 1989: 193-208.
21. Zetterquist H, Olerup O. Identification of the HLA-DRB1*04, DRB1*07 and -DRB1*09 alleles by PCR amplification with sequence specific primers (PCR-SSP) in 2 hours. Hum Immunol 1992: 34: 64-74.
22. Sanjeevi CB, Seshiah V, Möller E, Olerup O. Different genetic background for Type I diabetes and malnutrition related diabetes in South Indians. Diabetotogia 1992: 35: 283-286.
23. Rønningen KS, Iwe T, Halstensen TS, Spurkland A, Thorsby E. The amino acid at position 57 of the HLA-DQ beta chain and susceptibility to develop insulin-dependent diabetes mellitus. Human Immunol 1989: 26: 215-225.
24. Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet 1955: 19: 251-253.
25. Miettinen OS. The estimability and estimation on case reference studies. Am J Epidermiol 1976: 103: 226-235.
26. Verreck FAW, Termijtelen A, Koning F. HLA-DRβ chain residue 86 controls DRαβ dimer stability. Eur J Immunol 1993: 23: 1346-1350.
27. Svejgaard A, Ryder L. HLA and disease associations: detecting the strongest association. Tissue Antigens 1994: 43: 18-27.
28. Sanjeevi CB, Olerup O. Restriction fragment length polymorphism analysis of HLA-DRB, DQA and DQB genes in South Indians and Swedish Caucasians. Transplantation Proc 1992: 24: 1687-1688.
29. Awata T, Kuzuya T, Matsuda A, Iwamoto Y, Kanazawa Y. Genetic analysis of HLA class II alleles and susceptibility to Type 1 (insulin-dependent) diabetes mellitus in Japanese subjects. Diabetologia 1992: 35: 419-424.
30. Sheeny MJ, Scharf SJ, Rowe JR et al. A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and -DQ alleles. J Clin Invest 1989: 83: 830-835.
31. Wordsworth BP, Lanchbury JSS, Sakkas LI, Welsh KI, Panayi GS, Bell JI. HLA-DR4 subtype frequencies in rheumatoid arthritis indicate that DRB1 is the major susceptibility locus within the HLA class II region. Proc Natl Acad Sci U S A 1989: 86: 10049-10053.
32. Thorsby E, Rønningen KS. Particular HLA-DQ molecules play a dominant role in determining susceptibility or resistance to Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1993: 36: 371-377.
33. Krieger JI, Karr RW, Grey HM et al. Single amino acid changes in DR and antigen define residues critical for peptide-MHC binding and T cell recognition. J Immunol 1991: 146: 2331-2340.
34. Bush R, Hill CM, Hayball JD. Lamb JR, Rothbard JB. Effect of Natural polymorphism at residue 86 of the HLA-DRB chain on peptide binding. J Immunol 1991: 147: 1292-1298.
35. Ong B, Wilcox N, Wordsworth P et al. Critical role for the Val/Gly86 HLA-DRB dimorphism in autoantigen presentation to human T cells. Proc Natl Acad Sci U S A 1991: 88: 7343-7347.
36. Demotz S, Barbey C, Corradin G, Amoroso A, Lanzavecchia A. The set of naturally processed peptides displayed by DR molecules is tuned by polymorphism of residue 86. Eur J Immunol 1993: 23: 425-432.
37. Marshall KW, Liu AF. Canales J et al. Role of polymorphic residues in HLA-DR molecules in allele-specific binding of peptide ligands. J Immunol 1993: 152: 4946-4957.
38. Eckels DD, Geiger MJ, Sell TW, Gorski JA. Involvement of class II beta chain amino acid residues 85 and 86 in T cell allorecognition. Hum Immunol 1990: 27: 240-253.
39. Lang B, Navarette C, LoGalbo PR et al. Further DNA sequence microheterogeniety of the HLA-DR4/Dw13 haplotype group: importance of amino acid position 86 of the DRB1 chain for T cell recognition. Hum Immunol 1990: 27: 378-389.
40. Zeliszewski D, Tiercy JM, Dorval I, Kaplan C, Mach B, Sterkers G. DR-restricted T-cell reactivities associated with the Dw19 specificity can be directed against the products of either locus DRB3 (DRw52c) or locus DRB1. Hum Immunol 1990: 28: 345-353.
41. Johnson AH, Tang TF, Cowell V, Hurley CK. The impact of naturally occurring DR3 microvariants, DRw17 and DRw18 on T-cell allorecognition. Hum Immunol 1991: 32: 46-55.
42. de Koster HS, van Rood JJ, Termijtelen A. HLA-DR peptide induced alloreactive T cell lines reveal an HLA-DR sequence that can be both "dominant" and "cryptic": evidence for allele-specific processing. Eur J Immunol 1992: 22: 1531-1539.
43. Apple RJ, Erlich HA. Two new HLA DRB1 alleles found in African Americans: implications for balancing selection at position 57 and 86. Tissue Antigens 1992: 40: 69-74.
44. Petersdorf EW, Smith AG, Martin PJ, Hansen JA. HLA-DRB1 first domain sequence for a novel DR4 allele designated DRB1*0413. Tissue Antigens 1992: 40: 267-268.
45. Caillat-Zucman S, Garchon H-J, Timsit J et al. Age dependent HLA genetic heterogeniety of Type 1 insulin-dependent diabetes mellitus. J Clin Invest 1992: 90: 2242-2250.
46. Cucca F, Lampis R, Frau F et al. The distribution of DR4 haplotypes in Sardinia suggests a primary association of Type 1 diabetes with DRB1 and DQB1 loci. Hum Immunol 1995: 43: 301-308.
47. Erlich HA, Zeidler A, Chang J, Shaw S, Raffel LJ, Klitz W et al., HLA class II alleles and susceptibility and resistance to insulin-dependent diabetes mellitus in Mexican-American families. Nature Genet 1993: 3: 358-364.
48. Van der Auwera B, Waeyenberge CV, Schuit F et al. DRB1*0403 protects against IDDM in Caucasians with high risk heterozygous DQA1*0301-DQB1*0302/ DQA1*0501-DQB1*0201 genotype. Diabetes 1995: 44: 527-530.